The Riskalyze Report: Advisors Scoop Up the Non-Trump Trades

November 20th – November 26th

Among the sectors left behind in the initial burst of Trump Fever, biotechs and technology were the standouts. I guess because they’re both knowledge-based industries and globally focused as opposed to coal miners or gun sellers. I don’t even know anymore. Why technology and pharma should be viewed as “Hillary sectors” is beyond me, but this was the narrative.

But narratives don’t last. Advisors bought the dip (or, should I say, lag) in these sectors last week. Mike McDaniels, CIO of Riskalyze, tells me that “Advisor use of Biotech increased over 10% week over week.”

In the losers column, “Advisor use of Municipal Bonds, Utilities, and Precious Metals decreased by over 10% week over week.” This is more of that “sell yield” trend that’s emerged alongside the soaring rate on the 10-year and the market’s near certainty about a December rate hike.

*(to state the obvious, Riskalyze does not share client sensitive data with me or use animals in testing).